Log in to your Inderes Free account to see all free content on this page.
Create account

Optomed

1.50 EUR

-2.60 %

5,663 following

OPTOMED

NASDAQ Helsinki

Medical Equipment & Services

Health Care

-2.60 %
-30.97 %
-44.00 %
-60.27 %
-59.13 %
-63.55 %
-50.64 %
-87.52 %
-67.29 %

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

Read more
Market cap
32.14M EUR
Turnover
126.23K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Accumulate
Target price
Updated
07.05.2026
Disclaimer
Juha Kinnunen
Juha Kinnunen

Analyst

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
14.8.
2026

Interim report Q2'26

6.11.
2026

Interim report Q3'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Research, tools and community to support better investment decisions.

FREE account
The market's most popular morning review
Analysts' recommendations and comments
Stock comparison and the investor discussion forum
PREMIUM account
All company reports and analyses
Premium content: model portfolio, insider transactions, Premium articles
Inderes MCP: Inderes data directly into your AI tools
Create account
Forum discussions
There is no need to wonder much about the share price drop. OP has continued with large sales, Danske has continued with large sales, and compared to before, the largest shareholder, Sr Säästöpankki Pienyhtiöt, has sold a lot. At the same time, several large individual shareholders...
14 hours ago
by Due Diligence
17
Indeed. Well, pension companies will very soon be under heavy pressure to increase their equity weightings. It doesn’t take much of a side stream from pension funds towards small caps to create significant movement in small-cap share prices. Eläketurvakeskus – 1 Jun 26 Mikko Mursula...
13 hours ago
by Sheikki
10
To wrap up the end of May, another block trade: Optomed: Block trade at 18:32. 231,001 shares were sold at 1.538 euros per share, for a total value of 355,280 euros.
5/29/2026, 3:57 PM
by Mr. Stock
9
Based on Optomed’s own website, which was updated in March, the ESG work is already well underway. It shouldn’t take much longer to complete the ESG reporting required by the partner. Optomed Yritysvastuu Ympäristö- ja yhteiskuntavastuuseen sekä hallintotapaan liittyvät asiat (ESG...
5/29/2026, 3:49 PM
by Sheikki
9
At the same time, however, Murto—speaking for Varma—states that these funds will mostly be invested abroad. I don’t believe pension companies currently see Optomed as the kind of investment target worth sinking more money into - there are better options available. Tärkeimmät talousuutiset...
12 hours ago
by Jankkeri
6
In the closing auction, nearly 150k also went at the same price, totaling approximately 380k shares. I wonder if OP or Danske sold off the rest of their Optomed holdings after that active dumping. It’s a shame we probably won’t see who the buyer was from Monday’s shareholder list...
5/29/2026, 4:07 PM
by Bob Fleming
5
Indeed, Finnish legislation only requires a ridiculously clunky minimum level of information and accessibility regarding shareholder data. And many listed companies aren’t interested in making them available to shareholders on their investor pages very often. However, for example...
20 hours ago
by Opa
4
Read more on our forum

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.